ARCHIVES

Senate Committee Passes Bill To Speed FDA Approval Of Follow-On Biologics.

This article is from The Cancer Letter archive.

Vol. 33 No. 25 | June 29, 2007

Download PDF Visit The Full Archive

Related Articles

Avon to Support Community Programs

January 7, 1994

LAK/IL-2 Therapy Could Halt Kidney Cancer Deaths: DeVita

March 21, 1986

Eight CCRU, 20 CCSP Applications Submitted, Quality Is ‘Heartening’

November 19, 1982

Study Opens For Women At Risk of Ovarian Cancer

October 29, 2004

Former NCI Lab Deputy Charged With Two Criminal Counts

January 17, 1992

In Brief: NCHSR Says Autologous Marrow Transplant Is A “Reasonable Therapeutic Alternative”

August 11, 1989